Workflow
Bright Minds Biosciences (DRUG) - 2022 Q2 - Quarterly Report

Bright Minds Biosciences Inc. Condensed Interim Consolidated Financial Statements For the three and six months ended March 31, 2022 and 2021 (Expressed in Canadian Dollars) Bright Minds Biosciences Inc. Condensed Interim Consolidated Statements of Financial Position (Expressed in Canadian dollars - Unaudited) | --- | --- | --- | --- | |----------------------------------------------------|-------|--------------------|----------------------| | As at | Notes | March 31, 2022 | September 30, 2021 | | | | $ | $ ...